The Use of Paclitaxel-Coated Devices in the Treatment of Peripheral Arterial Disease is Not Associated With Increased Mortality or Amputations.

Evan C Bair,Beau C McCarver,Neal T Cooper,Benjamin A Greif,Matthew Major,Shengxuan Wang,Anthony J Lewis,Evan J Ryer,James R Elmore,Gregory G Salzler

Annals of vascular surgery（2022）

引用 0|浏览0

暂无评分

摘要

DCBS are not associated with increased mortality or worse amputation-free survival in this real-world cohort of patients treated for PAD. Our data suggest that mortality is more closely linked with pre-existing patient comorbidities rather than device selection at the time of revascularization.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要